|Last Price||Today's Change||52-Week Range||Trading Volume|
|61.62||0.70 (+1.15%)||46.30 - 64.44||346.9 thousand|
Market data as of 9:48AM 03/02/15. Quotes are delayed by at least 15 min.
U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Yervoy® (ipilimumab) as Adjuvant Treatment for Patients with Stage 3 Melanoma Who Are at High Risk of Recurrence
03/02/2015 9:25 AM ET